Old Web
Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial
2016
Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
56
References
32
Citations
NaN
KQI